Ware Olivia C
CIK 0001663771
Director
Filings
14
Latest Apr 28, 2026
Issuers covered
3
Showing
14 of 14
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 100% | +13.4% | +19.3% | +19.3% | +4.4% |
| 90 days | 5 | 60% | +6.7% | +21.0% | +21.0% | -14.7% |
| 180 days | 5 | 0% | -26.1% | -5.4% | -5.4% | -57.2% |
| 365 days | 5 | 0% | -5.8% | -3.0% | -3.0% | -9.9% |
Issuers
Companies where Ware Olivia C has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACLX | Arcellx, Inc. | 7 | Apr 28, 2026 |
| RVNC | Revance Therapeutics, Inc. | 5 | Feb 6, 2025 |
| CTNM | Contineum Therapeutics, Inc. | 2 | Jun 26, 2025 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|